跳转至内容
Merck
CN
所有图片(1)

文件

AB740

Sigma-Aldrich

Anti-Apolipoprotein A-I Antibody

serum, Chemicon®

登录查看公司和协议定价

别名:
ApoAI
UNSPSC代码:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物来源

goat

抗体形式

serum

抗体产品类型

primary antibodies

克隆

polyclonal

种属反应性

human

制造商/商品名称

Chemicon®

技术

western blot: suitable

NCBI登记号

UniProt登记号

运输

dry ice

靶向翻译后修饰

unmodified

特异性

Human apolipoprotein A-I. Monospecific by IEP.

应用

This Anti-Apolipoprotein A-I Antibody is validated for use in WB for the detection of Apolipoprotein A-I.

外形

Goat serum defibrinated, delipidized and adsorbed by solid phase chromatography as required. Liquid in 0.05M Tris-HCl, pH 7.5, 0.5M NaCl with 0.1% sodium azide.

法律信息

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Antonio Junior Lepedda et al.
Journal of circulating biomarkers, 8, 1849454419875912-1849454419875912 (2019-10-08)
Myasthenia gravis (MG) is an autoimmune disease leading to varying degrees of skeletal muscle weakness. It is caused by specific antibodies directed against definite components in the postsynaptic membrane at the neuromuscular junction (NMJ), such as the acetylcholine receptor (AChR)
Makoto Kurano et al.
PloS one, 12(5), e0177543-e0177543 (2017-05-12)
Sphingosine 1-phosphate (S1P) is a bioactive lipid mediator that is thought to be involved in various diseases. Although the main source of S1P in the plasma is erythrocytes, how S1P is exported from erythrocytes has not been elucidated. When we
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of serum amyloid A as a potential marker.
Lepedda, AJ; Nieddu, G; Zinellu, E; De Muro, P; Piredda, F; Guarino, A; Spirito, R; Carta et al.
Oxidative Medicine and Cellular Longevity null
Ronald W Clark et al.
Journal of lipid research, 47(3), 537-552 (2005-12-06)
We have identified a series of potent cholesteryl ester transfer protein (CETP) inhibitors, one member of which, torcetrapib, is undergoing phase 3 clinical trials. In this report, we demonstrate that these inhibitors bind specifically to CETP with 1:1 stoichiometry and
Charles E Chandler et al.
Journal of lipid research, 44(10), 1887-1901 (2003-07-03)
A microsomal triglyceride transfer protein (MTP) inhibitor, CP-346086, was identified that inhibited both human and rodent MTP activity [concentration giving half-maximal inhibition (IC50) 2.0 nM]. In Hep-G2 cells, CP-346086 inhibited apolipoprotein B (apoB) and triglyceride secretion (IC50 2.6 nM) without

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门